Stockscreener 앱 받기
0.919
8.50%
0.072
시장 영업 전:
.95
0.031
+3.37%
전일 마감가:
$0.847
열려 있는:
$0.86
하루 거래량:
519.41K
Relative Volume:
0.68
시가총액:
$8.54M
수익:
$2.05M
순이익/손실:
$-23.15M
주가수익비율:
-0.1386
EPS:
-6.6319
순현금흐름:
$-16.93M
1주 성능:
+3.27%
1개월 성능:
-79.16%
6개월 성능:
-67.75%
1년 성능:
-46.57%
1일 변동 폭
$0.81
$0.9307
1주일 범위
$0.6358
$1.00
52주 변동 폭
$0.6358
$6.8908
iBio Inc Stock (IBIO) Company Profile
명칭
iBio Inc
전화
302-355-0650
주소
600 Madison Avenue, Suite 1601, New York, NY
IBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
0.919 | 8.54M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-28 | 개시 | Chardan Capital Markets | Buy |
| 2021-11-29 | 개시 | JMP Securities | Mkt Outperform |
| 2021-01-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-06-26 | 개시 | Alliance Global Partners | Buy |
iBio Inc 주식(IBIO)의 최신 뉴스
Analytical Overview: TMC the metals company Inc (TMC)’s Ratios Tell a Financial Story - DWinneX
Financial Metrics Unveiled: CISO Global Inc (CISO)’s Key Ratios in the Spotlight - DWinneX
iBio - The Pharma Letter
AstralBio - The Pharma Letter
iBio Inc (IBIO) expanding its growth trajectory ahead - Sete News
Monitoring iBio Inc (IBIO) after recent insider movements - knoxdaily.com
In the Green: iBio Inc (IBIO) Closes at 0.70, Up/Down -17.43 from Previous Day - DWinneX
Ibio Inc Enters Exclusive License Agreement With AstralBio - marketscreener.com
iBio Enters Licensing Agreement for Obesity Treatment - TipRanks
iBio Inc (IBIO) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Breaking down IBIO’s current quarter earnings estimates - uspostnews.com
Revolutionary AI-Discovered Obesity Drug: iBio Licenses First-Ever Activin E Antibody in $28M Deal - Stock Titan
Porch Group Inc (PRCH) Stock: A Year of Stock Market Dynamics - investchronicle.com
iBio stock touches 52-week low at $1.03 amid market challenges By Investing.com - Investing.com South Africa
iBio stock touches 52-week low at $1.03 amid market challenges - Investing.com Australia
iBio Highlights Advancements in Obesity Antibody Programs - TipRanks
iBio Inc (NASDAQ: IBIO): Time To Buy Over The Next Few Months - Marketing Sentinel
iBio reports promising data on obesity treatment antibody By Investing.com - Investing.com South Africa
iBio reports promising data on obesity treatment antibody - Investing.com Australia
iBio stock touches 52-week low at $1.42 amid market challenges - Investing.com Australia
iBio stock touches 52-week low at $1.42 amid market challenges By Investing.com - Investing.com South Africa
Where Do Analysts Think The iBio Inc (NASDAQ: IBIO) Is Going - stocksregister.com
iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays Bearish - MSN
Ibio reports preclinical results for antibodies in cardiometabolic and obesity pipeline - BioWorld MedTech
Ibio IncOn Track For Regulatory Submission For Ibio-600 In Q1 2026 - MarketScreener
iBio Reveals Promising Study Results for IBIO-600 - TipRanks
iBio announces data from non-human primate PK study of IBIO-600 - TipRanks
Game-Changing Clinical Data: iBio's New Drug Combines Muscle Growth with Massive Weight Loss - Stock Titan
Senior Mining ExecutiveFrederic Mercier-Langevin to Join Patriot Battery Metals - The Globe and Mail
Hartford Insurance Group Inc.(The) [HIG] Officer makes an insider purchase of 1,144 shares worth 0.14 million. - knoxdaily.com
Galaxy Digital UK Secures FCA License, Expanding Derivatives Trading Capabilities in London - The Globe and Mail
iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World
iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World
iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World
Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World
IBIO Stock Price and Chart — NASDAQ:IBIO - TradingView
iBio Inc. stock rises Monday, outperforms market - MarketWatch
$IBIO stock is up 12% today. Here's what we see in our data. - Nasdaq
iBio Inc. stock rises Friday, outperforms market - MarketWatch
iBio Inc [IBIO] gain 106.12% so far this year. What now? - dbtnews.com
iBio Inc. stock rises Thursday, outperforms market - MarketWatch
iBio stock soars to 52-week high, reaches $5.03 - Investing.com
iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
iBio Inc. stock falls Monday, still outperforms market - MarketWatch
iBio, Inc. Advances in Therapeutics and Leadership - TipRanks
iBio Inc. stock falls Friday, underperforms market - MarketWatch
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
iBio Inc (IBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
36.06%
자본화:
|
볼륨(24시간):